pI: 6.9306 |
Length (AA): 453 |
MW (Da): 51641 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 444 | 1d5t (A) | 1 | 431 | 55.00 | 0 | 1 | 1.7 | -1.85 |
3 | 451 | 1s3e (A) | 3 | 461 | 12.00 | 0 | 1 | 0.86 | -0.23 |
2 | 444 | 3p1w (A) | 2 | 444 | 88.00 | 0 | 1 | 1.96252 | -1.35 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intraerythrocytic - 6 hs, intraerythrocytic - 12 hs, intraerythrocytic - 18 hs, intraerythrocytic - 24 hs, intraerythrocytic - 30 hs, intraerythrocytic - 36 hs. | Zhu L |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intraerythrocytic - 40 hs, intraerythrocytic - 48 hs. | Zhu L |
Zhu L | New insights into the Plasmodium vivax transcriptome using RNA-Seq. |
Ortholog group members (OG5_127353)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G44100 | guanosine nucleotide diphosphate dissociation inhibitor 1 |
Arabidopsis thaliana | AT3G59920 | RAB GDP dissociation inhibitor 2 |
Arabidopsis thaliana | AT5G09550 | RAB GDP-dissociation inhibitor |
Babesia bovis | BBOV_III001120 | GDP dissociation inhibitor rabGDI, putative |
Brugia malayi | Bm1_08800 | Rab GDP dissociation inhibitor alpha |
Candida albicans | CaO19.7261 | similar to GDP dissociation inhibitor |
Caenorhabditis elegans | CELE_Y57G11C.10 | Protein GDI-1, isoform C |
Cryptosporidium hominis | Chro.40465 | hypothetical protein |
Cryptosporidium parvum | cgd4_4080 | putative rab GDI alpha |
Dictyostelium discoideum | DDB_G0268034 | Rab GDP dissociation inhibitor alpha |
Drosophila melanogaster | Dmel_CG4422 | GDP dissociation inhibitor |
Echinococcus granulosus | EgrG_000767200 | rab gdp dissociation inhibitor |
Entamoeba histolytica | EHI_167060 | rab GDP dissociation inhibitor alpha, putative |
Entamoeba histolytica | EHI_164890 | rab GDP dissociation inhibitor alpha, putative |
Echinococcus multilocularis | EmuJ_000767200 | rab gdp dissociation inhibitor |
Giardia lamblia | GL50803_11495 | Rab GDI |
Homo sapiens | ENSG00000057608 | GDP dissociation inhibitor 2 |
Homo sapiens | ENSG00000203879 | GDP dissociation inhibitor 1 |
Leishmania braziliensis | LbrM.29.2140 | rab-GDP dissociation inhibitor, putative |
Leishmania donovani | LdBPK_292270.1 | rab-GDP dissociation inhibitor, putative |
Leishmania infantum | LinJ.29.2270 | rab-GDP dissociation inhibitor, putative |
Leishmania major | LmjF.29.2160 | rab-GDP dissociation inhibitor, putative |
Leishmania mexicana | LmxM.08_29.2160 | rab-GDP dissociation inhibitor, putative |
Loa Loa (eye worm) | LOAG_08943 | rab GDP dissociation inhibitor alpha |
Mus musculus | ENSMUSG00000015291 | guanosine diphosphate (GDP) dissociation inhibitor 1 |
Mus musculus | ENSMUSG00000021218 | guanosine diphosphate (GDP) dissociation inhibitor 2 |
Neospora caninum | NCLIV_022550 | GK15875, related |
Oryza sativa | 4338812 | Os05g0418000 |
Oryza sativa | 4332418 | Os03g0277000 |
Oryza sativa | 4342895 | Os07g0271000 |
Oryza sativa | 4338357 | Os05g0304400 |
Plasmodium berghei | PBANKA_1456200 | rab specific GDP dissociation inhibitor, putative |
Plasmodium falciparum | PF3D7_1242800 | rab specific GDP dissociation inhibitor |
Plasmodium knowlesi | PKNH_1462100 | rabGDI protein, putative |
Plasmodium vivax | PVX_101040 | rab GDP dissociation inhibitor beta, putative |
Plasmodium yoelii | PY04102 | rabGDI protein |
Saccharomyces cerevisiae | YER136W | Gdi1p |
Schistosoma japonicum | Sjp_0093470 | Rab GDP dissociation inhibitor alpha, putative |
Schistosoma japonicum | Sjp_0093460 | Rab GDP dissociation inhibitor alpha, putative |
Schistosoma mansoni | Smp_094420 | rab GDP-dissociation inhibitor |
Schistosoma mansoni | Smp_024520 | rab GDP-dissociation inhibitor |
Schmidtea mediterranea | mk4.001161.09 | |
Trypanosoma brucei gambiense | Tbg972.3.5210 | RAB GDP dissociation inhibitor alpha, putative |
Trypanosoma brucei | Tb927.3.4680 | RAB GDP dissociation inhibitor alpha, putative |
Trypanosoma congolense | TcIL3000_3_2890 | RAB GDP dissociation inhibitor alpha, putative |
Trypanosoma cruzi | TcCLB.510329.60 | RAB GDP dissociation inhibitor alpha, putative |
Toxoplasma gondii | TGME49_202380 | rab GDI alpha, putative |
Theileria parva | TP03_0715 | rab GDP dissociation inhibitor, putative |
Trichomonas vaginalis | TVAG_126970 | RAB GDP-dissociation inhibitor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.4680 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.4680 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.4680 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.4680 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y57G11C.10 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_Y57G11C.10 | Caenorhabditis elegans | sterile | wormbase |
YER136W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_202380 | Toxoplasma gondii | Probably essential | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2